Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
February 02 2022 - 7:00AM
Business Wire
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced
that Steve Hoerter, President and Chief Executive Officer, will
present virtually at the following investor conferences:
- Guggenheim 2022 Oncology Virtual Conference on February 9, 2022
at 8:30 AM ET
- 11th Annual SVB Leerink Global Healthcare Conference on
February 16, 2022 at 3:40 PM ET
A live webcast of both events will be available on the “Events
and Presentations” page in the “Investors” section of the Company’s
website at https://investors.deciphera.com/events-presentations. A
replay of both webcasts will be archived on the Company’s website
for 90 days following the presentation.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering,
developing, and commercializing important new medicines to improve
the lives of people with cancer. We are leveraging our proprietary
switch-control kinase inhibitor platform and deep expertise in
kinase biology to develop a broad portfolio of innovative
medicines. In addition to advancing multiple product candidates
from our platform in clinical studies, QINLOCK® is Deciphera’s
switch-control inhibitor for the treatment of fourth-line GIST.
QINLOCK is approved in Australia, Canada, China, the European
Union, Hong Kong, Switzerland, Taiwan, the United Kingdom, and the
United States. For more information, visit www.deciphera.com and
follow us on LinkedIn and Twitter (@Deciphera).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220202005016/en/
Investor Relations: Maghan Meyers Argot Partners
Deciphera@argotpartners.com 212-600-1902
Media: David Rosen Argot Partners
David.Rosen@argotpartners.com 212-600-1902
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
From Jul 2023 to Jul 2024